Navigation Links
ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
Date:3/18/2008

ADDISON, Texas, March 18 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) announced today that Kerry P. Gray, the company's President and Chief Executive Officer, will provide a corporate presentation at the Cowen and Company 28th Annual Health Care Conference in Boston, MA on March 20, 2008 at 11:00 a.m. Eastern time.

Interested investors and others may also listen to the presentation, hosted by Cowen and Company, live and by replay at http://www.corporateir.net/ireye/conflobby.zhtml?ticker=ULU&item_id=1780912 and clicking on the link for this webcast. Access to the webcast is not password protected.

About ULURU Inc.:

ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company

Kerry P. Gray

President & CEO

Terry K. Wallberg

Vice President & CFO

(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
2. ULURU Inc. Reports Third Quarter 2007 Results
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
4. ULURU Inc. Announces Odd-Lot Buy Back Offer
5. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
6. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
7. Smart Balance to Webcast Presentation at Citi Small/Midcap Conference
8. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
9. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
10. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
11. Hologic to Present at Lehman Brothers Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its ... manufactured in Warner, New Hampshire at the MadgeTech headquarters. With products sold in more ... trusted by government agencies, including NASA. , In 2012, NASA strategically set up ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James ... Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the ... founder of Retina Group of New York , is a Board Certified ...
(Date:5/26/2016)... ... 2016 , ... In an effort to provide hair restoration information to the widest possible audience, ... who do not use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, ... . , Dr. Mohebi says, “The positive response to the Snapchat videos we started ...
(Date:5/26/2016)... ... 2016 , ... Leadership of Life Science Logistics (LSL), a ... earned its ISO 13485 certification, indicating the company’s quality control system for medical ... associated with ISO quality standard 13485. , BSI Group America, Inc., a ...
(Date:5/26/2016)... ... 2016 , ... The Lung Institute has partnered with the Gulfcoast ... June 6 at their clinic in downtown Tampa. The class is complimentary for the ... has created a free downloadable 4 Week Smoking Cessation Guide for those ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 Inivata, ... precision of circulating tumour DNA (ctDNA) analysis to ... appointment of Professor Clive Morris as ... across the clinical development programme, scientific collaborations, and ... deliver significant improvements in clinical outcomes for patients. ...
(Date:5/24/2016)...   , Study met ... and superiority in , Excellent plus ... of the ascending colon   , ... B.V. today announced new positive data from the phase III MORA ... standard 2 litre PEG with ascorbate. The study met both primary ...
(Date:5/24/2016)... VMS BioMarketing as senior vice president of sales, announced Andrea Heslin Smiley , ... the company,s business development and sales team, exploring new opportunities for VMS to empower ... ... ... ...
Breaking Medicine Technology: